Realestate News

Land identified for pharma council at Parawada

Parawada news in vizag picture

It will boost exports from North Andhra, says investors

After several rounds of discussions, the State government has finally identified land at Parawada for allotment to Pharmaceutical Export Promotion Council of India popularly known as PHARMEXCIL to set up a regional campus.

Sources told The Hindu that an area of 20 acres had been earmarked for allotment to PHARMEXCIL between Jawaharlal Nehru Pharma City (JNPC) and MRO office at Parawada, about 50 km from here.

Chief Minister N. Chandrababu Naidu during his recent tour to the city said they would allot the land to PHARMEXCIL shortly to woo investors to pharma sector. Representatives of the council have made several visits to the city to expedite the process for acquiring land during past few months.

The campus will have several facilities for research and development, conferences, reference material and testing mechanism. PHARMEXCIL was set up in 2004 by the Ministry of Commerce and Industries in association with the captains of the industry to promote exports from the country. The council will facilitate registrations, hold exhibitions by bringing buyers and sellers to a common platform, disseminate trade queries, offer consultancy services to increase exports of bulk drugs, intermediaries and formulations. The campus will also house the offices of senior officials from the Director-General of Foreign Trade and Drug Control Administration.

Pharma hub

North Andhra is the only area in Andhra Pradesh post-bifurcation to have a well developed pharma cluster. JNPC at Parawada itself is developed in an area of 2400 acres of which 611 acres is designated as a Special Economic Zone. Second Pharma City is also proposed at Atchutapuram.

“A campus of PHARMEXCIL will make North Andhra a prominent hub,” said JNPC CEO P.P. Lal Krishna. The presence of the campus would also help sort out several issues with regard to exports, he said. “Registrations and raising export turnover manifold will be possible once PHARMEXCIL sets up its campus here,” Eisai Pharmaceuticals India Managing Director Sanjit Singh Lamba said, adding “the campus will boost the climate of exports.”

Though there are no statistics available on pharma exports from North Andhra as some of the major companies route their exports from Hyderabad and other metros, JNPC, where 73 units are in operations and 20 plus at various stages of construction, has an annual turnover of Rs.15,000 crore with a workforce of 20,000.